Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Br J Haematol. 2015 Oct 22;172(3):392–400. doi: 10.1111/bjh.13834

Table III.

Multivariate analysis of covariates for disease-free survival

Parameter Hazard ratio
(95% confidence interval)
P value
At Complete Remission (N=260)

Age 1.017 (1.005, 1.029) 0.006
WBC 1.003 (1.002, 1.005) <0.0001
Cytogenetics 0.89 (0.61, 1.30) 0.54
MRD at CR 1.47 (1.003, 2.153) 0.048

At 3 Months from Therapy Initiation (N=215)

Age 1.016 (1.004, 1.028) 0.01
WBC 1.003 (1.002, 1.005) <0.0001
Cytogenetics 0.92 (0.64, 1.34) 0.68
MRD at 3 Months 1.72 (0.79, 3.73) 0.17

At 6 Months from Therapy Initiation (N=166)

Age 1.015 (1.003, 1.027) 0.014
WBC 1.003 (1.001, 1.005) 0.0003
Cytogenetics 0.98 (0.67, 1.42) 0.90
MRD at 6 Months 2.12 (0.70, 6.44) 0.18

WBC, white blood cell count; MRD, minimal residual disease; CR, complete remission